Sameer Imtiaz

3.4k total citations · 1 hit paper
62 papers, 2.2k citations indexed

About

Sameer Imtiaz is a scholar working on Epidemiology, Pharmacology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Sameer Imtiaz has authored 62 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Epidemiology, 23 papers in Pharmacology and 19 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Sameer Imtiaz's work include Substance Abuse Treatment and Outcomes (39 papers), Cannabis and Cannabinoid Research (23 papers) and Opioid Use Disorder Treatment (19 papers). Sameer Imtiaz is often cited by papers focused on Substance Abuse Treatment and Outcomes (39 papers), Cannabis and Cannabinoid Research (23 papers) and Opioid Use Disorder Treatment (19 papers). Sameer Imtiaz collaborates with scholars based in Canada, Germany and Russia. Sameer Imtiaz's co-authors include Jürgen Rehm, Kevin D. Shield, Michael Roerecke, Andriy V. Samokhvalov, Omer S. M. Hasan, Charlotte Probst, Svetlana Popova, Paul A. Shuper, Gerhard Gmel and Gerrit Gmel and has published in prestigious journals such as SHILAP Revista de lepidopterología, European Respiratory Journal and Journal of Affective Disorders.

In The Last Decade

Sameer Imtiaz

54 papers receiving 2.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The relationship between different dimensions of alcohol use and the burden of disease—an update

2017 776 citations Jürgen Rehm, Omer S. M. Hasan et al. Addiction profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sameer Imtiaz Canada	22	1.2k	623	582	509	327	62	2.2k
Ron A. Cisler United States	22	1.6k 1.4×	561 0.9×	538 0.9×	270 0.5×	449 1.4×	59	2.8k
Benjamin H. Han United States	24	775 0.7×	216 0.3×	417 0.7×	702 1.4×	364 1.1×	75	1.9k
Ed Day United Kingdom	28	1.1k 1.0×	236 0.4×	627 1.1×	190 0.4×	844 2.6×	139	2.6k
Dolly Baliunas Canada	17	2.1k 1.7×	1.5k 2.4×	828 1.4×	150 0.3×	491 1.5×	41	3.5k
Carolin Kilian Germany	19	841 0.7×	533 0.9×	534 0.9×	130 0.3×	152 0.5×	74	1.8k
Adenekan Oyefeso United Kingdom	26	801 0.7×	277 0.4×	589 1.0×	220 0.4×	371 1.1×	65	1.8k
Marissa B. Esser United States	21	771 0.7×	388 0.6×	354 0.6×	85 0.2×	249 0.8×	44	1.4k
Jeanette M. Tetrault United States	28	1.4k 1.1×	166 0.3×	563 1.0×	581 1.1×	1.2k 3.6×	100	3.0k
Richard K. Fuller United States	23	1.4k 1.2×	810 1.3×	324 0.6×	271 0.5×	216 0.7×	43	2.5k
Anika Alvanzo United States	21	478 0.4×	144 0.2×	260 0.4×	147 0.3×	330 1.0×	42	1.2k

Countries citing papers authored by Sameer Imtiaz

Since Specialization

Citations

This map shows the geographic impact of Sameer Imtiaz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sameer Imtiaz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sameer Imtiaz more than expected).

Fields of papers citing papers by Sameer Imtiaz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sameer Imtiaz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sameer Imtiaz. The network helps show where Sameer Imtiaz may publish in the future.

Co-authorship network of co-authors of Sameer Imtiaz

This figure shows the co-authorship network connecting the top 25 collaborators of Sameer Imtiaz. A scholar is included among the top collaborators of Sameer Imtiaz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sameer Imtiaz. Sameer Imtiaz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Imtiaz, Sameer, et al.. (2025). Public support of and attitudes toward decriminalization of possession of illegal drugs among the general population in British Columbia. Substance Abuse Treatment Prevention and Policy. 20(1). 50–50. 1 indexed citations

Ali, Farihah, Cayley Russell, Sameer Imtiaz, et al.. (2025). Characterizing changes to harm reduction site operations in British Columbia following the implementation of the decriminalization of drugs: Findings from a provincial survey. Harm Reduction Journal. 22(1). 122–122. 1 indexed citations

Rehm, Jürgen, Farihah Ali, Cayley Russell, et al.. (2025). Decriminalization of drug possession in British Columbia and hospitalizations for opioid poisoning. Public Health. 248. 105915–105915.

Imtiaz, Sameer, Huan Jiang, Cayley Russell, et al.. (2025). The Short‐Term Impacts of Decriminalisation of Personal Possession of Select Illegal Drugs on Drug Poisonings in British Columbia, Canada (2015–2023). Drug and Alcohol Review. 44(7). 1856–1865.

Nigatu, Yeshambel T., Samantha Wells, Lena C. Quilty, et al.. (2025). Non-medical use of prescription opioids: use to experience subjective effects vs. other non-medical use among adults in Ontario, Canada from 2020 to 2024. Journal of Studies on Alcohol and Drugs.

Russell, Cayley, Kate Hodgson, Rita Shahin, et al.. (2025). Examining opioid agonist treatment (OAT) site operations and early signals of change in the first year of British Columbia’s drug decriminalization policy: Insights from a provincial survey. Canadian Journal of Public Health. 116(4). 518–530. 1 indexed citations

Cantor, Nathan, Brian Hutton, Tara Elton‐Marshall, et al.. (2024). The association between physical availability of cannabis retail outlets and frequent cannabis use and related health harms: a systematic review. The Lancet Regional Health - Americas. 32. 100708–100708. 19 indexed citations

Imtiaz, Sameer, et al.. (2024). Trends in drug overdose deaths among adults 65 years of age and older in Canada (2000–2022). SHILAP Revista de lepidopterología. 12. 100254–100254. 2 indexed citations

Imtiaz, Sameer, Yeshambel T. Nigatu, Farihah Ali, et al.. (2023). Cannabis legalization and cannabis use, daily cannabis use and cannabis-related problems among adults in Ontario, Canada (2001–2019). Drug and Alcohol Dependence. 244. 109765–109765. 40 indexed citations

10.

Russell, Cayley, et al.. (2023). The impact of methamphetamine use on medications for opioid use disorder (MOUD) treatment retention: a scoping review. Addiction Science & Clinical Practice. 18(1). 48–48. 4 indexed citations

11.

Myran, Daniel T., et al.. (2022). Changes in health harms due to cannabis following legalisation of non‐medical cannabis in Canada in context of cannabis commercialisation: A scoping review. Drug and Alcohol Review. 42(2). 277–298. 27 indexed citations

12.

Barbosa, Carolina, William N. Dowd, Simon Neuwahl, et al.. (2022). Modeling the impact of COVID‐19 pandemic‐driven increases in alcohol consumption on health outcomes and hospitalization costs in the United States. Addiction. 118(1). 48–60. 15 indexed citations

13.

Imtiaz, Sameer, Frishta Nafeh, Cayley Russell, et al.. (2021). The impact of the novel coronavirus disease (COVID-19) pandemic on drug overdose-related deaths in the United States and Canada: a systematic review of observational studies and analysis of public health surveillance data. Substance Abuse Treatment Prevention and Policy. 16(1). 87–87. 58 indexed citations

14.

Probst, Charlotte, Tara Elton‐Marshall, Sameer Imtiaz, et al.. (2020). A supportive school environment may reduce the risk of non-medical prescription opioid use due to impaired mental health among students. European Child & Adolescent Psychiatry. 30(2). 293–301. 4 indexed citations

15.

Imtiaz, Sameer, Samantha Wells, Jürgen Rehm, et al.. (2020). Cannabis Use During the COVID-19 Pandemic in Canada: A Repeated Cross-sectional Study. Journal of Addiction Medicine. 15(6). 484–490. 61 indexed citations

16.

Imtiaz, Sameer, Michael Roerecke, Paul Kurdyak, et al.. (2019). Brief Interventions for Cannabis Use in Healthcare Settings: Systematic Review and Meta-analyses of Randomized Trials. Journal of Addiction Medicine. 14(1). 78–88. 26 indexed citations

17.

Hassan, Ahmed N., Bernard Le Foll, Sameer Imtiaz, & Jürgen Rehm. (2017). The effect of post-traumatic stress disorder on the risk of developing prescription opioid use disorder: Results from the National Epidemiologic Survey on Alcohol and Related Conditions III. Drug and Alcohol Dependence. 179. 260–266. 54 indexed citations

18.

Fischer, Benedikt, Sameer Imtiaz, Katherine Rudzinski, & Jürgen Rehm. (2015). Crude estimates of cannabis-attributable mortality and morbidity in Canada–implications for public health focused intervention priorities. Journal of Public Health. 38(1). 183–188. 49 indexed citations

19.

Lev‐Ran, Shaul, Sameer Imtiaz, & Bernard Le Foll. (2012). Self‐Reported Psychotic Disorders among Individuals with Substance Use Disorders: Findings from the National Epidemiologic Survey on Alcohol and Related Conditions. American Journal on Addictions. 21(6). 531–535. 6 indexed citations

20.

Lev‐Ran, Shaul, Sameer Imtiaz, Benjamin J. Taylor, et al.. (2011). Gender differences in health-related quality of life among cannabis users: Results from the national epidemiologic survey on alcohol and related conditions. Drug and Alcohol Dependence. 123(1-3). 190–200. 88 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact